Catalent Inc. (CTLT)
63.48
0.00 (0.00%)
At close: Dec 17, 2024, 9:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 11.52B |
| Revenue (ttm) | 4.41B |
| Net Income (ttm) | -411.89M |
| EPS (ttm) | -2.28 |
| PE Ratio (ttm) | -27.84 |
| Forward PE | 33.66 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 13,674,041 |
| Avg. Volume (20D) | 2,227,006 |
| Open | 63.49 |
| Previous Close | 63.48 |
| Day's Range | 63.44 - 63.50 |
| 52-Week Range | 42.11 - 63.50 |
| Beta | 1.16 |
About CTLT
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use...
Sector Healthcare
IPO Date Jul 31, 2014
Employees 17,000
Stock Exchange NYSE
Ticker Symbol CTLT
Website https://www.catalent.com
Next Earnings Release
Catalent Inc. is scheduled to release its earnings on Feb 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 year ago
+9.74%
Catalent shares are trading higher after the compa...
Unlock content with
Pro Subscription
